I've held back adding my 2c whilst trading - but feel like a bit of a tart as that was a wonderful chance to average down.
Obviously there are Growth stocks and there are Return stocks - MYX needs to be growth, as currently they are in no position to return - whilst we can talk Operating Cash v Cash Cash - to me it is all $cash. If you don't have it, you're in debt or your doors are closed.
I'm ignoring the commentary - here - and just talking first glance.... Still burning cash.
So we need to be growth:
And the kicker - Nextstellis - 5.8% is growth - but considering the focus - sucks.
The *growth* hasn't continued - so easy to see why there would be selling. If you're an investor in for the long-term, with a sprinkle of faith in management, there is still need to believe the commentary... There is a *reason* given for all, so without commentary the results are disappointing. Adding in the commentary and what we know.
Nextstellis numbers - New selling team combined with the following commentary:
If we can have 15+% in the next quarter - that's a positive result given the grind of the last 18 months.
Cashflow - One off payment to make one (of ?two) potential head ache go away
All of a sudden, cashflow - not just Operating, but $Cash is King flow, is positive. Massive TICK
Dermatology - Probably a little less certain here as the commentary *could* be a concern. But let's believe all is Rosey and we'll exceed 2H Rev in 1H
If MYX can get over $5 this run and not be FK'd by Trump or Results which expose dodgy arse commentary in their update (like Nextstellis showing <10% growth (after the commentary provided) at 1H results, or Derm rev drop not being seasonal but actually underperform by a brand or two), then some of the volatility of the stock should be *gone* and there is *NO* reason why we wouldn't see some institutional investors back into the stock.
GLTA
(20min delay)